ACT 2 Logo
TREATMENT · ESTRIOL VAGINAL CREAM · SYMPTOM

Vaginal Estrogen, Bladder Symptoms and the Pelvic Floor

The bladder symptoms of menopause arrive quietly and are almost never connected to it. Needing to go more often. Needing to go now. Getting up twice a night. A leak on a cough, a laugh, a run. Women in their fifties absorb these as aging, buy the products, and do not mention them to anyone — and the two treatments that address most of it go unused.

This page is about those two treatments: estriol vaginal cream, which restores the tissue, and pelvic-floor physiotherapy, which retrains the muscle. Neither is complete without the other, which is why this page covers both.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.

The tissue half

The urethra, the neck of the bladder and the front wall of the vagina share an embryological origin and share estrogen receptors. Loss of estrogen thins all of them together. The urethral lining loses its cushioning, its blood supply and its seal; the bladder neck loses support; the bladder itself becomes more irritable and its lining more sensitive. The result is the cluster now grouped under genitourinary syndrome of menopause: urgency, frequency, nocturia, discomfort on urination, and — as the UTI page covers — recurrent infection.

Local vaginal estrogen reverses the thinning in the tissue it touches, and the urethra and bladder neck are within reach. Trials and reviews find that it reduces urgency, frequency and nocturia, and improves the urethral seal; it is recommended for urgency symptoms in postmenopausal women by the American Urological Association and the Society of Urodynamics.

One distinction worth knowing: local vaginal estrogen improves urinary symptoms; systemic oral estrogen, in the WHI, slightly worsened incontinence. It is the same route lesson as everywhere else on this site — the tissue needs estrogen applied to it, not estrogen swallowed.

The muscle half

The pelvic floor is a sling of muscle that holds the bladder, uterus and bowel in place and closes the outlets on demand. It weakens with childbirth, with age, with the loss of estrogen's support for its connective tissue, and with the habit — nearly universal — of never training it.

Stress incontinence — the leak on a cough or a jump — is largely a muscle-and-support problem. Urgency is partly tissue and partly a bladder that has learned to signal too early, which is also retrainable. Neither is fixed by estrogen alone.

Pelvic-floor physiotherapy is a specialist discipline, not a leaflet of exercises. A trained physiotherapist assesses the muscles directly, identifies whether they are weak, over-tight or poorly coordinated — over-tightness is common and is made worse by the standard advice to "do more Kegels" — and builds a program accordingly. The evidence is strong: supervised pelvic-floor training is the first-line treatment for stress and mixed incontinence in every major guideline, with cure or improvement in a majority of women who complete it.

Together, the two treatments address both halves. Estrogen restores the tissue the muscle works against; the physiotherapy restores the muscle. A woman who does only one often gets a partial result and concludes that nothing works.

What we do, and what we refer

We prescribe the estrogen, and we ask about the symptoms — because most women will not raise them unprompted, and because urgency, nocturia and leaking are on the assessment for exactly that reason.

We refer for pelvic-floor physiotherapy, and we mean it as a recommendation rather than a courtesy. It is available in most cities, often covered by insurance, and it is the treatment with the best evidence for the muscular half of the problem.

We also refer, before either, where the picture needs it: blood in the urine, pain, a sudden change, incomplete emptying, a history of pelvic surgery or radiotherapy, or a prolapse the woman can feel. Those are a urologist's or urogynecologist's assessment first. Local estrogen can still be part of the plan; it is not the first step.

What to expect

Tissue improvement — less irritation, less urgency, fewer night-time trips — usually within weeks of starting local estrogen, building over three months. Muscle improvement follows the physiotherapy timeline, which is months rather than weeks and depends on doing the program. Both are treatments to continue: the tissue reverts if the estrogen stops, and the muscle detrains if the exercises do.

Questions

Frequently asked questions

  • Yes — local vaginal estrogen reduces urgency, frequency and night-time urination in postmenopausal women and is recommended for those symptoms by the AUA. Oral estrogen does not have the same effect and may worsen incontinence.

  • Partly. Stress incontinence is mostly a muscle-and-support problem; estrogen restores the tissue, pelvic-floor physiotherapy restores the muscle. Both together work best.

  • Specialist assessment and training of the pelvic-floor muscles by a trained physiotherapist — not a leaflet of Kegels. It is first-line treatment for stress and mixed incontinence in every major guideline.

  • Some women can; many do them wrong, and some have an over-tight pelvic floor that Kegels make worse. An assessment tells you which you are.

  • Blood in the urine, pain, sudden change, incomplete emptying, prior pelvic surgery or radiotherapy, or a prolapse you can feel.

  • Usually within weeks, building over about three months. It is a treatment to continue, not a course to finish.

Your next step

Where this fits in your plan

The Estriol Vaginal Cream page covers the product. Say the bladder symptoms out loud at assessment — they are treatable, and they are the part women most often leave out.

We measure first. Then we act.

References

  1. Cody JD et al. Estrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database of Systematic Reviews 2012.
  2. Lightner DJ et al. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. Journal of Urology 2019;202:558–563.
  3. Dumoulin C et al. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews 2018.
  4. Hendrix SL et al. Effects of estrogen with and without progestin on urinary incontinence (WHI). JAMA 2005;293:935–948.
  5. The Menopause Society. The 2020 Genitourinary Syndrome of Menopause Position Statement. Menopause 2020;27:976–992.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

We measure first. Then we act.

Start with a baseline. Then decide about estriol vaginal cream.